The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,746.00
Bid: 4,732.00
Ask: 4,736.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.085%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,746.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Dec 2019 07:00

RNS Number : 8814W
Croda International PLC
16 December 2019
 

16 December 2019

 

Croda International Plc

 

Appointment of Non-Executive Director - Board succession planning

 

The Board of Croda International Plc is pleased to announce the appointment of John Ramsay as a Non-Executive Director with effect from 1 January 2020.

 

John, a Chartered Accountant, served as Chief Financial Officer of Syngenta AG from 2007 to 2016 and was also Interim Chief Executive Officer from October 2015 to June 2016. Prior to this, John served as Group Financial Controller of Syngenta from 2000 to 2007 and as the Finance Head of Asia Pacific for Zeneca Agrochemicals from 1993 to 1999. Earlier in his career he was a Financial Controller of ICI Malaysia and regional controller for Latin America. Before joining ICI in 1984, he worked in audit and tax at KPMG. John is a member of the Supervisory Board at Koninklijke DSM N.V. and a Non-Executive Director of G4S plc and RHI Magnesita N.V. He is Audit Committee Chair on all three boards.

 

On joining the Board, John will be appointed to the Audit, Nomination and Remuneration Committees.

 

Alan Ferguson will retire from the Board on 23 April 2020 following the AGM after nine years as a Non-Executive Director. John Ramsay will take over as Chair of the Audit Committee and Helena Ganczakowski will take on the role as Senior Independent Director. Helena has been on the Board since February 2014 and is the Chair of the Remuneration Committee.

 

Anita Frew, Chair of Croda International Plc, commented:

 

"John brings with him a wealth of financial, international and sector experience. John has a Life Sciences background with ICI, AstraZeneca and Syngenta and brings a deep emerging market experience from his 10 years living and working in Asia and from his work in Latin America. We are delighted to welcome him to the Board. John's appointment in January 2020 will allow for a period of hand over before he takes the role as Audit Committee Chair in April 2020. His strong background as an Audit Committee Chair will be of enormous benefit to the Croda Board and complement and enhance the significant expertise we already have on the Board.

 

"I am delighted that Helena Ganczakowski is stepping up to become Senior Independent Director. She has extensive Board experience and has demonstrated strong leadership of the Remuneration Committee.

 

"Alan Ferguson has made an outstanding contribution to the Board, both as Audit Committee Chair and Senior Non-Executive Director, and, on behalf of the Board and his colleagues, we thank him for all his advice and support and wish him all the best for the future."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

 

 

Enquiries:

 

Jez Maiden, Group Finance Director, Croda International Plc

investor.relations@croda.com

+44 (0)1405 860551

 

Charlie Armitstead, Teneo

charles.armitstead@teneo.com 

+44 (0)7703 330 269

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMMMMZKFNGLZM
Date   Source Headline
15th May 20175:16 pmRNSDirector/PDMR Shareholding
15th May 20175:13 pmRNSDirector/PDMR Shareholding
15th May 20175:06 pmRNSDirector/PDMR Shareholding
15th May 20175:04 pmRNSDirector/PDMR Shareholding
15th May 20174:56 pmRNSDirector/PDMR Shareholding
15th May 20174:14 pmRNSDirector/PDMR Shareholding
15th May 20171:57 pmRNSTransaction in Own Shares
11th May 20173:01 pmRNSDirector/PDMR Shareholding
27th Apr 201710:09 amRNSResult of AGM
26th Apr 20177:00 amRNSTrading Update for the First Quarter 2017
11th Apr 20173:35 pmRNSDirector/PDMR Shareholding
23rd Mar 20173:27 pmRNSDirector/PDMR Shareholding
20th Mar 20175:45 pmRNSAnnual Financial Report
16th Mar 20173:45 pmRNSDirector/PDMR Shareholding
13th Mar 20172:20 pmRNSDirector/PDMR Shareholding
10th Mar 20174:39 pmRNSDirector/PDMR Shareholding
9th Mar 20174:53 pmRNSDirector/PDMR Shareholding
9th Mar 20179:50 amRNSDirector/PDMR Shareholding
28th Feb 20177:02 amRNSDr Keith Layden to become a Non-Executive Director
28th Feb 20177:00 amRNSResults for the year ended 31 December 2016
14th Feb 201710:37 amRNSDirector/PDMR Shareholding
11th Jan 20174:06 pmRNSDirector/PDMR Shareholding
20th Dec 20165:25 pmRNSDirector/PDMR Shareholding
13th Dec 20165:23 pmRNSDirector/PDMR Shareholding
24th Nov 20162:39 pmRNSHolding(s) in Company
21st Nov 20164:12 pmRNSDirector/PDMR Shareholding
11th Nov 20163:01 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSTrading update for the third quarter of 2016
2nd Nov 20162:59 pmRNSHolding(s) in Company
1st Nov 201611:19 amRNSDirector/PDMR Shareholding
31st Oct 20165:31 pmRNSHolding(s) in Company
31st Oct 20163:17 pmRNSDirector/PDMR Shareholding
18th Oct 20169:15 amRNSHolding(s) in Company
12th Oct 20167:01 amRNSDirector Declaration
11th Oct 20165:44 pmRNSDirector/PDMR Shareholding
7th Oct 20164:06 pmRNSHolding(s) in Company
6th Oct 20165:32 pmRNSHolding(s) in Company
5th Oct 20165:54 pmRNSDirector/PDMR Shareholding
5th Oct 20163:47 pmRNSHolding(s) in Company
16th Sep 201611:50 amRNSDirector/PDMR Shareholding
13th Sep 20165:30 pmRNSHolding(s) in Company
13th Sep 20164:49 pmRNSDirector/PDMR Shareholding
12th Sep 20165:07 pmRNSHolding(s) in Company
11th Aug 20163:01 pmRNSDirector/PDMR Shareholding
5th Aug 20164:51 pmRNSHolding(s) in Company
5th Aug 20163:28 pmRNSDirector/PDMR Shareholding
4th Aug 20169:40 amRNSHolding(s) in Company
2nd Aug 20165:17 pmRNSHolding(s) in Company
2nd Aug 20165:13 pmRNSHolding(s) in Company
27th Jul 20165:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.